Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4343)
All Articles published online
|
Oct 24, 2012 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Transplantation
ISSN
2220-3230
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Salvadori M. Antineoplastic effects of mammalian target of rapamycine inhibitors. World J Transplant 2012; 2(5): 74-83 [PMID: 24175199 DOI: 10.5500/wjt.v2.i5.74] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3230/full/v2/i5/74.htm |
| Number | Citing Articles |
| 1 |
Omar Abdel-Rahman, Mona Fouad. Risk of mucocutaneous toxicities in patients with solid tumors treated with everolimus; a systematic review and meta-analysis. Expert Review of Anticancer Therapy 2014; 14(12): 1529 doi: 10.1586/14737140.2014.953936
|
| 2 |
Tal Gilboa, Reeval Segel, Sharon Zeligson, Gheona Alterescu, Hilla Ben-Pazi. Ganglioglioma, Epilepsy, and Intellectual Impairment due to Familial TSC1 Deletion. Journal of Child Neurology 2018; 33(7): 482 doi: 10.1177/0883073818767036
|
| 3 |
Kengo Shimazu, Yuji Tada, Takao Morinaga, Masato Shingyoji, Ikuo Sekine, Hideaki Shimada, Kenzo Hiroshima, Takao Namiki, Koichiro Tatsumi, Masatoshi Tagawa. Metformin produces growth inhibitory effects in combination with nutlin-3a on malignant mesothelioma through a cross-talk between mTOR and p53 pathways. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3300-y
|
| 4 |
Alessandro C. Rosa, Marco Finocchietti, Nera Agabiti, Paolo Menè, Maria Elena Bracaccia, Arianna Bellini, Marco Massari, Stefania Spila Alegiani, Lucia Masiero, Gaia Bedeschi, Massimo Cardillo, Ersilia Lucenteforte, Giuseppe Piccolo, Olivia Leoni, Eliana Ferroni, Silvia Pierobon, Maurizio Nordio, Stefano Ledda, Donatella Garau, Marina Davoli, Antonio Addis, Valeria Belleudi, Francesca R. Poggi, Maria Lucia Marino, Claudia Marino, Ursula Kirchmayer, Andrea Ricci, Francesca Puoti, Vito Sparacino, Pamela Fiaschetti, Silvia Trapani, Alessandra Oliveti, Daniela Peritore, Lorella Lombardozzi, Manuel Zorzi, Martina Zanforlini, Arianna Mazzone, Michele Ercolanoni, Andrea Angelo Nisic, Paolo Carta, Valentina Ientile, Luca L’Abbate, Matilde Tanaglia, Gianluca Trifirò, Ugo Moretti. Determinants of immunosuppressive therapy in renal transplant recipients: an Italian observational study (the CESIT project). BMC Nephrology 2023; 24(1) doi: 10.1186/s12882-023-03325-9
|
| 5 |
Po-Ming Chow, Shing-Hwa Liu, Yu-Wei Chang, Kuan-Lin Kuo, Wei-Chou Lin, Kuo-How Huang. The covalent CDK7 inhibitor THZ1 enhances temsirolimus-induced cytotoxicity via autophagy suppression in human renal cell carcinoma. Cancer Letters 2020; 471: 27 doi: 10.1016/j.canlet.2019.12.005
|
| 6 |
Omar Abdel-Rahman, Mona Fouad. Risk of fatigue and hepatic and metabolic toxicities in patients with solid tumors treated with everolimus: a meta-analysis. Future Oncology 2015; 11(1): 79 doi: 10.2217/fon.14.136
|
| 7 |
Anna Julie Peired, Alessandro Sisti, Paola Romagnani. Renal Cancer Stem Cells: Characterization and Targeted Therapies. Stem Cells International 2016; 2016: 1 doi: 10.1155/2016/8342625
|